David Hung
President and CEO at Nuvation Bio Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Nuvation Bio Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
NovoCure Limited June 3, 202697.5%
-
NovoCure Limited June 4, 202599.4%
-
Nuvation Bio Inc. May 21, 2025100.0%
-
NovoCure Limited June 5, 202498.8%
-
NovoCure Limited June 7, 202398.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | NovoCure Limited | Grant or award | +11,610 | — | — |
| Jun 2, 2026 | NovoCure Limited | Open-market sale | −2,945 | $15.77 | $46,443 |
| Jun 16, 2025 | Nuvation Bio Inc. | Open-market purchase | +500,000 | $1.79 | $895,000 |
| Jun 4, 2025 | NovoCure Limited | Grant or award | +11,215 | — | — |
| Jun 3, 2025 | NovoCure Limited | Open-market sale | −999 | $17.30 | $17,283 |
| Apr 7, 2025 | Nuvation Bio Inc. | Open-market purchase | +300,000 | $1.63 | $489,000 |
| Apr 4, 2025 | Nuvation Bio Inc. | Open-market purchase | +200,000 | $1.66 | $332,000 |
| Jun 5, 2024 | NovoCure Limited | Grant or award | +4,053 | — | — |
| Mar 2, 2021 | Nuvation Bio Inc. | Other | −368,408 | — | — |
Questions about David Hung
What boards is David Hung on?
David Hung sits on the boards of NovoCure Limited and Nuvation Bio Inc.
Has David Hung been a CEO?
Yes — David Hung was CEO of Nuvation Bio Inc. (Until April 2024).
How long has David Hung served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.